An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and assertions of next-day British shipping. Sellers market the substance there before directing customers to other platforms for transactions.
Understanding Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Voice Concerns
However, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users injecting substances of unknown origin.
Several professionals stated the demand for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.
Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or prison.
Platform Response and Content Removal
Based on the social media company, the service has removed problematic material and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also found groups with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.
After minutes of entering one community, a vendor posted WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.
Item Details and Costs
Inside these communities, messages show black plastic packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how long a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for Telegram stated it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to possibly serious health risks”.
